PETSPetMed Express Inc.
- Next report
- No date yet
- none in the next 8 weeks
- Last result
- −$0.31Missed
- vs −$0.11 expected on Nov 10
- Price
- $1.06
- −12.40% today · $41.5M cap
Past and upcoming reports
1
| Nov 10, 2026 | Sep 30, 2026 | After the market closes | −$0.11 | Missed−$0.31 |
After the report
Nov 10, 2026 report
PETS EPS miss drove a 12.4% selloff to $1.06
PetMed Express reported fiscal-second-quarter EPS of -$0.31 versus -$0.11 estimated, while shares fell 12.4% to $1.06 on November 11.
Reported against expected
MissedReported EPS was -$0.31 versus -$0.11 estimated, a -$0.20 or 181.8% miss for the quarter ended September 30, 2026.
Guidance
No explicit management guidance or post-earnings guidance commentary was provided in the available data. next-year EPS growth was estimated at 28.6%.
How the stock reacted
Shares fell $0.15, or 12.4%, from $1.21 to $1.06 on November 11, with 403,347 shares traded.
What changed
EPS was -$0.31, versus the -$0.11 estimate, creating a $0.20 downside surprise.
What the price now assumes
The 12.4% decline to $1.06 signals intensified concern after a 47.5% six-month share-price loss.
What it means for the business
Downgrade bias until EPS recovers. require a reported quarterly improvement and price reclaim above the $1.8355 EMA20.
The next one to three months, as we saw it then
Better case25%
A recovery case requires the projected 28.6% next-year EPS growth to become credible through improving quarterly results.
Base case50%
The stock remains range-bound while investors weigh the EPS miss against the 28.6% projected next-year EPS growth.
Worse case25%
The downside case extends if the -$0.31 EPS result reflects persistent operating weakness rather than a one-quarter setback.
If you hold it
Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.
If you are watching
Enter only after quarterly EPS improves and shares reclaim $1.8355. do not trade while shares remain below $1.8355 without evidence supporting the 28.6% next-year EPS forecast.
Scenario odds are a judgement, not measured.